Neonatal outcomes after neuraminidase inhibitor use during pregnancy: a meta-analysis of cohort studies.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15033
Abstract: AIM Influenza infection poses a severe threat to pregnant mothers, and antiviral treatment is recommended. However, the safety of neuraminidase-inhibitor antiviral medications during pregnancy has not been well described. METHODS A systematic review and meta-analysis… read more here.
Keywords: pregnancy; inhibitor; neuraminidase inhibitor; exposure neuraminidase ... See more keywords